Skip to main content
Loading

Working to move gene therapies from lab-scale to commercial readiness.

18 Sep 2025
Gene Therapy CMC & Process Development
Focusing on key aspects such as: Upstream/downstream process intensification, scalable plasmid, AAV, and LNP production, analytical method development and validation, comparability and bridging studies, regulatory expectations and global alignment, facility design and tech transfer challenges.